TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
Authors
Keywords
-
Journal
BIOINFORMATICS
Volume 32, Issue 17, Pages i413-i420
Publisher
Oxford University Press (OUP)
Online
2016-09-01
DOI
10.1093/bioinformatics/btw449
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- A community effort to assess and improve drug sensitivity prediction algorithms
- (2014) James C Costello et al. NATURE BIOTECHNOLOGY
- Investigating the prediction ability of survival models based on both clinical and omics data: two case studies
- (2014) Riccardo De Bin et al. STATISTICS IN MEDICINE
- Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects
- (2013) Santosh Vishwakarma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Data, information, knowledge and principle: back to metabolism in KEGG
- (2013) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data
- (2012) Wenting Wang et al. BIOINFORMATICS
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
- (2011) J. Jing et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail
- (2010) Gajanan S. Inamdar et al. BIOCHEMICAL PHARMACOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- MAPK signaling pathways in the regulation of hematopoiesis
- (2009) Christian R. Geest et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells
- (2008) Toru Furukawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now